Orofino Gold Corp. (PINK OTC: ORFG) (”Orofino Gold” or the “Company”) has several Gold development properties in Colombia, a current hot spot of gold production in the world markets.

The company is please to announce that the Board Of Directors have appointed Mr. Ning Shi Long as Chairman of the Board and Executive Director.

Mr. Ary Fernando Pernett Marque has been appointed as the new President/CEO & Executive Director of Orofino Gold Corp. (see full resume on the company website at www.orofinogold.com)

Mr. Pernett will be responsible for all affairs of the Company in Colombia. Mr. Pernett has 30 years of experience working in the Colombian Mining sector and will over the near term choose his new development team to assist in the development of the company’s Senderos de Oro gold camp in the Sur de Bolivar Colombia.

The company and Mr. Pernett will continue to work with Contexto Legal of Medellin and Bogota, the company’s legal counsel as well as Discovery Consultants, (The Qualified 43-101 team) Canada, as they have in the past. The new team will now aggressively pursue other known Gold occurrences in the companies Senderos de Oro Gold Camp while the development team works to improve production at La Azul Mine.

The Board of Director’s have accepted resignation of John T. Martin, former Managing Director of the Company. His resignation is effective immediately. The Company wish him well and success in future endeavors.

Power3 Medical Products, Inc. (PWRM.OB)

Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, recently announced that company management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, to name a few.

In addition, Power3 is a party to several litigation matters, most of which relate to various toxic debt instruments that were entered into by Power3 several years ago when it operated under the tenure of Chairman and CEO, Steven B. Rash. Because current management believes these toxic debt instruments are responsible for Power3’s depressed stock price and have distracted the company from its mission, Power3 plans to settle as many of these nagging lawsuits as possible prior to the completion of its merger with Rozetta-Cell Life Sciences, Inc. As for those lawsuits that cannot be speedily resolved, Power3 will continue to rigorously defend its position. For example, one such lawsuit involves Neogenomics, Inc., which was recently granted a motion for summary judgment with respect to an amount due under a convertible debenture. Power3 intends to appeal this decision.

“We are very excited to be finally ridding ourselves of litigation that has plagued us for several years now,” stated Ira L. Goldknopf, President and Chief Scientific Officer of Power3 Medical Products, Inc. “We have big plans for the future beginning with our upcoming acquisition of Rozetta-Cell and are about to enter a long and substantial growth phase marked by advances in our science and intellectual property. Given the imminent nature of many of these transactions and breakthroughs, we have decided, in consultation with the financiers of Rozetta-Cell, that the best course of action for Power3 is to settle many of these lawsuits so that we can focus our attention exclusively on the acquisition of Rozetta-Cell and the development of our combined businesses after the merger.”

Rozetta-Cell Life Sciences, Inc. is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. Power3 plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company. The acquisition of Rozetta-Cell is expected to be completed in February 2011.

Universal American Corp. (NYSE:UAM) the nation’s second largest Medicare Part D plan sponsor(1) with its Community CCRx Prescription Drug plans, recently named Peterson Drug and Gifts in Mountain Lake, Minn., the 2010 Community CCRx Pharmacy of the Year. Owner Vernon Peterson and pharmacy staff were recognized for their commitment to medication therapy management, Community CCRx and Universal American’s Healthy Collaboration.
Universal American Corp., together with its subsidiaries, provides health insurance and managed care products and services primarily to the senior population in the United States. It operates in four segments: Senior Managed Care Medicare Advantage, Medicare Part D, Traditional Insurance, and Senior Administrative Services.

Eaton Vance Senior Floating Rate Trust (NYSE:EFR) announced the monthly distributions declared on the common shares of two of its closed-end bank loan funds (the “Funds”). As portfolio and market conditions change, the rate of future distributions may change. The distributions are expected to be paid on January 12, 2011, to shareholders of record on December 31, 2010. The ex-date is December 29, 2010. The declaration, record and payment dates of the regular January distribution have been accelerated to allow the Funds to meet their 2010 distribution requirements for federal excise tax purposes.
Eaton Vance Senior Floating Rate Trust is a closed-ended fixed income mutual fund launched and managed by Eaton Vance Management. The fund invests in fixed income markets of the United States. It invests in fixed income securities operating across diversified sectors.

Main Street Capital Corporation (NYSE:MAIN) updates regarding the status of negotiations with ChemChina.Koor Industries Ltd has reached agreements concerning strategic cooperation with ChemChina (hereinafter “ChemChina”), a large Chinese company controlled by the Chinese Government active in the areas of chemicals and agrochemicals. According to the agreements, the Company together with Koor and the China National Agrochemical Corporation, part of the ChemChina Group, subject to approval by their Boards of Directors and by the Company’s Audit Committee, are expected to sign within about two weeks on the agreement by which a merger will take place, whereby the public holdings in the Company will be purchased and the Company will become a privately held company (hereinafter “the Transaction”).
Main Street Capital Corporation is a business development company specializing in equity, equity related, and debt investments in small and lower middle market companies. The firm focuses on investments in warrants, PIK (Payment in Kind) interest, convertible securities, junior secured or unsecured, subordinated loans, mezzanine investments, management buyouts, ownership transitions, recapitalizations, strategic acquisitions, business expansion, growth financings, and other growth initiatives primarily for later stage businesses.

Sign up for free stock alerts at http://www.pennygovernance.com/signup

***************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyGovernance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyGovernance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more @ http://pennygovernance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 500,000 shares of 144 stock in Orofino Gold Corp. (PINK SHEETS: ORFG) valued at sixty five thousand dollars, and 500,000 shares of free trading shares valued at sixty five thousand dollars from a third party (QU CUI You) for 30 days advertising. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

***************************************